A one-fifth dose of yellow fever vaccine protects against yellow fever for 10 years and does not require a booster. Findings from a follow-up study of a randomized controlled, non-inferiority trial are published in Annals of Internal Medicine.
Yellow fever is an acute viral hemorrhagic disease that is spread by infected mosquitoes. In a recent outbreak of urban yellow fever in Angola and the Democratic Republic of Congo, 4,347 suspected cases and 377 deaths were reported from December 2015 to October 2016. Since there is no cure, vector control and vaccination are essential for prevention. Outbreaks of yellow fever and a frequently depleted vaccine stock increase demand for a dose-sparing strategy. A fractional dose of 17D yellow fever virus (17D-YFV) vaccine has been shown to be non-inferior to the standard dose for inducing a protective immune response, but whether this dose provides long-term protection is not known.
Researchers from Leiden University Medical Center, Leiden, the Netherlands, studied 10 year follow-up data on a subgroup of patients from the trial to evaluate whether fractional-dose vaccination conferred long-term immunity. They found that 97 percent of participants had protective levels of yellow-fever neutralizing antibodies more than 10 years after receiving fractional dose of 17D-YFV vaccine compared with 34 of 35 who received the standard dose. According to the researchers, this is one of the first studies to document long-term protection after fractional-dose yellow fever vaccination. These findings reinforce the policy of using fractional doses in preventive mass vaccination campaigns before an impeding outbreak and also show that a booster dose is not necessary.
Source: American College of Physicians
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.